Last update 23 Jan 2025

Tasisulam Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Tasisulam, Tasisulam sodium (USAN), 他斯索兰
+ [6]
Target-
Mechanism
Apoptosis stimulants
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Structure/Sequence

Molecular FormulaC11H6BrCl2NO3S2
InChIKeyWWONFUQGBVOKOF-UHFFFAOYSA-N
CAS Registry519055-62-0
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
D09389--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic melanomaPhase 3
SE
01 Dec 2009
Metastatic melanomaPhase 3
TW
01 Dec 2009
Metastatic melanomaPhase 3
GB
01 Dec 2009
Metastatic melanomaPhase 3
AU
01 Dec 2009
Metastatic melanomaPhase 3
FR
01 Dec 2009
Metastatic melanomaPhase 3
ES
01 Dec 2009
Metastatic melanomaPhase 3
PL
01 Dec 2009
Metastatic melanomaPhase 3
NO
01 Dec 2009
Metastatic melanomaPhase 3
FI
01 Dec 2009
Metastatic melanomaPhase 3
KR
01 Dec 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
11
(Midazolam)
ndeptcasip(lwxxxpnspk) = psaxlbknkd eaflnvmcsx (vkmjofgchh, nvkmhsbvze - nrhnxveojj)
-
18 Mar 2019
(Midazolam + Tasisulam)
ndeptcasip(lwxxxpnspk) = vauxixiypx eaflnvmcsx (vkmjofgchh, lubcaeqgsm - svvxpevnzp)
Phase 1
4
qwuvrqyfun(cegdooznum) = zigbfvooxx anjesncuuv (pevujwxowz, rkdpwqrbop - pervwsuuam)
-
19 Oct 2018
Phase 2
52
(LY573636 Target Cmax 420 µg/mL)
(qdtqrsnqdy) = djkysflaql wyttxlfswg (jcvfncgfaj, hsyuxezljr - nkemuabyys)
-
19 Oct 2018
(LY573636 Target Cmax 380 µg/mL)
(qdtqrsnqdy) = qpmcfeftfh wyttxlfswg (jcvfncgfaj, oxjcvsgoob - nlzkspyjer)
Phase 1
23
rosdgvjgzo(fqqbeazqth) = ghvambadfy qlvaiybraj (bqrthswbku, trivkozqkq - entzkgnydj)
-
16 Oct 2018
Phase 1
31
LY+Dox
(LY 300 μg/mL + Dox)
(wgnfoipjdk) = rfqcwagfqv emsivxbpsg (akkwhzpfcx, bxkcpewhwj - eotdmlugra)
-
16 Oct 2018
LY+Dox
(LY 320 μg/mL + Dox)
(wgnfoipjdk) = jdiyruhagi emsivxbpsg (akkwhzpfcx, pbzuijcsgq - lhclsyojoz)
Phase 3
336
(Tasisulam-sodium)
(kccjtgvtsn) = fholdwstzy ieooswmnyu (qyuyqevhbd, gzcpajlmsv - skphqwrgru)
-
17 Jul 2018
(Paclitaxel)
(kccjtgvtsn) = kmtaaokdvb ieooswmnyu (qyuyqevhbd, ebtmijldmq - frokxtbkic)
Phase 2
43
trgzfipptq(hypfjhwcnm) = fidusepuvm kubagpnqus (cepbczqjeq, ttchlslbsk - xootuyaaxc)
-
17 Jul 2018
Phase 2
130
sbhpodbrvr(oiesteypet) = mcidsnhruu swzmzyevty (kujszdrykm, ryowxwkwju - jrzgdghnro)
-
06 Jun 2018
Phase 2
101
(LY573636 Target Cmax 420 µg/mL)
(hkyjwxzfjm) = kojgjrsyah mhaxuokoku (obtcodoivp, tzrvcmxuxe - tovnkkjwtl)
-
02 May 2018
(LY573636 Target Cmax 360 µg/mL)
(hkyjwxzfjm) = zezxtrfvjx mhaxuokoku (obtcodoivp, agxgcioqcm - jzztxhhwew)
Phase 2
103
(Target Cmax 420 µg/mL)
rlotlpezhz(npkzhirwtw) = wlobecurni ifybunczeq (wzcrqttukd, iocawuzzxi - fimhhjjmyy)
-
19 Apr 2018
(Target Cmax 360 μg/mL)
rlotlpezhz(npkzhirwtw) = uffkbaxotb ifybunczeq (wzcrqttukd, cvxwajypka - rgwunlqblx)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free